150 related articles for article (PubMed ID: 37810970)
1. Response assessment of post-treatment head and neck cancers to determine further management using NI-RADS (Neck Imaging Reporting and Data System): a subgroup analysis of a randomized controlled trial.
Mahajan A; Unde H; Sable NP; Shukla S; Vaish R; Patil V; Agarwal U; Agrawal A; Noronha V; Joshi A; Kapoor A; Menon N; Agarwal JP; Laskar SG; Dcruz AK; Chaturvedi P; Pai P; Rane SU; Bal M; Patil A; Prabhash K
Front Oncol; 2023; 13():1200366. PubMed ID: 37810970
[TBL] [Abstract][Full Text] [Related]
2. Interrater Reliability of NI-RADS on Posttreatment PET/Contrast-enhanced CT Scans in Head and Neck Squamous Cell Carcinoma.
Hsu D; Rath TJ; Branstetter BF; Anzai Y; Phillips CD; Juliano AF; Mosier KM; Bazylewicz MP; Poliashenko SM; Kulzer MH; Rhyner PA; Risk B; Wiggins RH; Aiken AH
Radiol Imaging Cancer; 2021 May; 3(3):e200131. PubMed ID: 34018845
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic Performance of Response Assessment FDG-PET/CECT in HNSCC Treated With Definitive Radio(chemo)therapy Using NI-RADS.
Paul S; Gupta T; Purandare N; Joshi K; Ghosh-Laskar S; Budrukkar A; Swain M; Sinha S; Kumar A; Joshi A; Prabhash K; Nair S; Rangarajan V; Agarwal JP
Otolaryngol Head Neck Surg; 2023 Oct; 169(4):938-947. PubMed ID: 36856038
[TBL] [Abstract][Full Text] [Related]
4. Performance of NI-RADS on CECT Alone to Predict Recurrent Head and Neck Squamous Cell Carcinoma after Chemoradiotherapy: Added Value of RECIST 1.1.
Kumar I; Reza SO; Choudhary S; Shukla RC; Mani N; Verma A
Indian J Radiol Imaging; 2022 Jun; 32(2):151-158. PubMed ID: 35924129
[No Abstract] [Full Text] [Related]
5. Predictive Value of First Posttreatment Imaging Using Standardized Reporting in Head and Neck Cancer.
Hsu D; Chokshi FH; Hudgins PA; Kundu S; Beitler JJ; Patel MR; Aiken AH
Otolaryngol Head Neck Surg; 2019 Dec; 161(6):978-985. PubMed ID: 31331239
[TBL] [Abstract][Full Text] [Related]
6. Interreader reproducibility of the Neck Imaging Reporting and Data system (NI-RADS) lexicon for the detection of residual/recurrent disease in treated head and neck squamous cell carcinoma (HNSCC).
Abdelaziz TT; Abdel Razk AAK; Ashour MMM; Abdelrahman AS
Cancer Imaging; 2020 Aug; 20(1):61. PubMed ID: 32811559
[TBL] [Abstract][Full Text] [Related]
7. Retrospective Evaluation of NI-RADS for Detecting Postsurgical Recurrence of Oral Squamous Cell Carcinoma on Surveillance CT or MRI.
Dinkelborg P; Ro SR; Shnayien S; Schaafs LA; Koerdt S; Kreutzer K; Heiland M; Hamm B; Elsholtz FHJ
AJR Am J Roentgenol; 2021 Jul; 217(1):198-206. PubMed ID: 32876497
[No Abstract] [Full Text] [Related]
8. Negative Predictive Value of NI-RADS Category 2 in the First Posttreatment FDG-PET/CT in Head and Neck Squamous Cell Carcinoma.
Wangaryattawanich P; Branstetter BF; Hughes M; Clump DA; Heron DE; Rath TJ
AJNR Am J Neuroradiol; 2018 Oct; 39(10):1884-1888. PubMed ID: 30166429
[TBL] [Abstract][Full Text] [Related]
9. MRI Posttreatment Surveillance for Head and Neck Squamous Cell Carcinoma: Proposed MR NI-RADS Criteria.
Ashour MM; Darwish EAF; Fahiem RM; Abdelaziz TT
AJNR Am J Neuroradiol; 2021 Jun; 42(6):1123-1129. PubMed ID: 33707288
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Value of Radiological Extranodal Extension Detected by Computed Tomography for Predicting Outcomes in Patients With Locally Advanced Head and Neck Squamous Cell Cancer Treated With Radical Concurrent Chemoradiotherapy.
Mahajan A; Chand A; Agarwal U; Patil V; Vaish R; Noronha V; Joshi A; Kapoor A; Sable N; Ahuja A; Shukla S; Menon N; Agarwal JP; Laskar SG; D' Cruz A; Chaturvedi P; Chaukar D; Pai PS; Pantvaidya G; Thiagarajan S; Rane S; Prabhash K
Front Oncol; 2022; 12():814895. PubMed ID: 35719994
[TBL] [Abstract][Full Text] [Related]
11. Neck Imaging Reporting and Data System Category 3 on Surveillance Computed Tomography: Incidence, Biopsy Rate, and Predictive Performance in Head and Neck Squamous Cell Carcinoma.
Johansson ED; Hughes RT; Meegalla NT; Porosnicu M; Patwa HS; Lack CM; Bunch PM
Laryngoscope; 2022 Sep; 132(9):1792-1797. PubMed ID: 35043989
[TBL] [Abstract][Full Text] [Related]
12. Adding MR Diffusion Imaging and T2 Signal Intensity to Neck Imaging Reporting and Data System Categories 2 and 3 in Primary Sites of Postsurgical Oral Cavity Carcinoma Provides Incremental Diagnostic Value.
Jajodia A; Mandal G; Yadav V; Khoda J; Goyal J; Pasricha S; Puri S; Dewan A
AJNR Am J Neuroradiol; 2022 Jul; 43(7):1018-1023. PubMed ID: 35738671
[TBL] [Abstract][Full Text] [Related]
13. Reliability of NI-RADS criteria in the interpretation of contrast-enhanced magnetic resonance imaging considering the potential role of diffusion-weighted imaging.
Elsholtz FHJ; Erxleben C; Bauknecht HC; Dinkelborg P; Kreutzer K; Hamm B; Niehues SM
Eur Radiol; 2021 Aug; 31(8):6295-6304. PubMed ID: 33533989
[TBL] [Abstract][Full Text] [Related]
14. Initial Performance of NI-RADS to Predict Residual or Recurrent Head and Neck Squamous Cell Carcinoma.
Krieger DA; Hudgins PA; Nayak GK; Baugnon KL; Corey AS; Patel MR; Beitler JJ; Saba NF; Liu Y; Aiken AH
AJNR Am J Neuroradiol; 2017 Jun; 38(6):1193-1199. PubMed ID: 28364010
[TBL] [Abstract][Full Text] [Related]
15. Impact of double reading on NI-RADS diagnostic accuracy in reporting oral squamous cell carcinoma surveillance imaging - a single-center study.
Elsholtz FHJ; Ro SR; Shnayien S; Dinkelborg P; Hamm B; Schaafs LA
Dentomaxillofac Radiol; 2022 Jan; 51(1):20210168. PubMed ID: 34233509
[TBL] [Abstract][Full Text] [Related]
16. Performance of the Neck Imaging Reporting and Data System as applied by general neuroradiologists to predict recurrence of head and neck cancers.
Lee J; Kaht D; Ali S; Johnson S; Bullen J; Karakasis C; Lamarre E; Geiger J; Koyfman S; Stock S
Head Neck; 2022 Oct; 44(10):2257-2264. PubMed ID: 35801334
[TBL] [Abstract][Full Text] [Related]
17. A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer.
Patil VM; Noronha V; Joshi A; Agarwal J; Ghosh-Laskar S; Budrukkar A; Murthy V; Gupta T; Mahimkar M; Juvekar S; Arya S; Mahajan A; Agarwal A; Purandare N; Rangarajan V; Balaji A; Chaudhari SV; Banavali S; Kannan S; Bhattacharjee A; D'Cruz AK; Chaturvedi P; Pai PS; Chaukar D; Pantvaidya G; Nair D; Nair S; Deshmukh A; Thiagarajan S; Mathrudev V; Manjrekar A; Dhumal S; Maske K; Bhelekar AS; Nawale K; Chandrasekharan A; Pande N; Goel A; Talreja V; Simha V; Srinivas S; Swami R; Vallathol DH; Dsouza H; Shrirangwar S; Turkar S; Abraham G; Thanky AH; Patel U; Pandey MK; Prabhash K
Cancer; 2019 Sep; 125(18):3184-3197. PubMed ID: 31150120
[TBL] [Abstract][Full Text] [Related]
18. Initial Referring Physician and Radiologist Experience with Neck Imaging Reporting and Data System.
Bunch PM; Meegalla NT; Abualruz AR; Frizzell BA; Patwa HS; Porosnicu M; Williams DW; Aiken AH; Hughes RT
Laryngoscope; 2022 Feb; 132(2):349-355. PubMed ID: 34272871
[TBL] [Abstract][Full Text] [Related]
19. Relative value of ultrasound, computed tomography and positron emission tomography imaging in the clinically node-negative neck in oral cancer.
Chaukar D; Dandekar M; Kane S; Arya S; Purandare N; Rangarajan V; Deshmukh A; Pai P; Chaturvedi P; D'Cruz A
Asia Pac J Clin Oncol; 2016 Jun; 12(2):e332-8. PubMed ID: 25131685
[TBL] [Abstract][Full Text] [Related]
20. FDG-PET/contrast-enhanced CT as a post-treatment tool in head and neck squamous cell carcinoma: comparison with FDG-PET/non-contrast-enhanced CT and contrast-enhanced CT.
Suenaga Y; Kitajima K; Ishihara T; Sasaki R; Otsuki N; Nibu K; Minamikawa T; Kiyota N; Sugimura K
Eur Radiol; 2016 Apr; 26(4):1018-30. PubMed ID: 26188656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
